BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7628052)

  • 1. Selective inhibition of cell proliferation and DNA synthesis by the polysulphated carbohydrate l-carrageenan.
    Hoffman R; Burns WW; Paper DH
    Cancer Chemother Pharmacol; 1995; 36(4):325-34. PubMed ID: 7628052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of chick muscle satellite cells by fibroblast growth factors: interaction with insulin-like growth factor-I and heparin.
    Wilkie RS; O'Neill IE; Butterwith SC; Duclos MJ; Goddard C
    Growth Regul; 1995 Mar; 5(1):18-27. PubMed ID: 7538368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of adipocyte precursor DNA synthesis by acidic and basic fibroblast growth factors: interaction with heparin and other growth factors.
    Butterwith SC; Peddie CD; Goddard C
    J Endocrinol; 1993 Jun; 137(3):369-74. PubMed ID: 7690390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of a laminarin sulphate which inhibits basic fibroblast growth factor binding and endothelial cell proliferation.
    Hoffman R; Paper DH; Donaldson J; Alban S; Franz G
    J Cell Sci; 1995 Nov; 108 ( Pt 11)():3591-8. PubMed ID: 8586670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrageenans inhibit growth-factor binding.
    Hoffman R
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):331-4. PubMed ID: 8424778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
    Hoffman R; Dennis IF; Donaldson J
    Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
    Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate.
    Djakiew D; Pflug B; Onoda M
    Adv Exp Med Biol; 1993; 330():185-202. PubMed ID: 8368133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol inhibits basic fibroblast growth factor-mediated proliferation of C6 astrocytoma cells.
    Luo J; Miller MW
    J Neurochem; 1996 Oct; 67(4):1448-56. PubMed ID: 8858926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.
    Fenig E; Wieder R; Paglin S; Wang H; Persaud R; Haimovitz-Friedman A; Fuks Z; Yahalom J
    Clin Cancer Res; 1997 Jan; 3(1):135-42. PubMed ID: 9815549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of binding of basic fibroblast growth factor to low and high affinity receptors by carrageenans.
    Hoffman R; Sykes D
    Biochem Pharmacol; 1993 Jun; 45(11):2348-51. PubMed ID: 8517877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen.
    Kay EP; Gu X; Ninomiya Y; Smith RE
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):663-72. PubMed ID: 8449685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.
    Shain SA; Lin AL; Koger JD; Karaganis AG
    Endocrinology; 1990 Feb; 126(2):818-25. PubMed ID: 2153528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
    Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.